Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs Sionna Therapeutics, Inc. (SION)

Inovio Pharmaceuticals, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and Sionna Therapeutics, Inc. are of similar size ($168.7M and $167.5M). Across the 9 metrics below, Sionna Therapeutics, Inc. leads on 7 and Inovio Pharmaceuticals, Inc. on 2.

Valuation

Metric INO SION Biotechnology median
P/E n/m n/m 10.26
P/S 310.99 n/m 9.18
P/B 27.45 0.56 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.56 0.65
EV/Sales 259.00 n/m 8.98
Earnings yield (78.57%) (65.86%) (34.89%)
Free cash flow yield (66.73%) (51.05%) (24.52%)

Profitability

Metric INO SION Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) (32.34%) (50.12%)
Return on assets (114.64%) (30.66%) (45.60%)
Return on invested capital 0.00% (125.00%) 0.00%

Growth

Metric INO SION Biotechnology median
Revenue growth (TTM) (54.82%) — 6.26%
EPS growth (last fiscal year) 54.18% 88.24% 29.88%
Revenue growth, 5-year CAGR (61.18%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric INO SION Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 20.05 4.89
Net debt to EBITDA 0.70 2.58 1.01

Dividend

Metric INO SION Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INO SION Biotechnology median
Market cap 167.50m 168.65m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack